Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. iv infusion
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Iv Infusion Articles & Analysis

4 articles found

Improving Clinical Practice Can Benefit Staff and Patients  - Case Study

Improving Clinical Practice Can Benefit Staff and Patients - Case Study

The staff placed a 20-gauge peripheral IV and infused a 1-liter NS bolus using the LifeFlow PLUS and the QinFlow Warrior blood and fluid warmer. After a slight improvement, he received 1 unit of PRBCs. Post-infusion, his vital signs improved to BP 99/61, HR 114, SI 1.15, and his skin went from gray to pale. ...

By410 Medical


Drug Delivery: What do Patients and Providers Want?

Drug Delivery: What do Patients and Providers Want?

While innovations that improve patient access to care evolve, understanding the needs and wants of patients and providers is more important than ever. CURRENT DRUG DELIVERY OPTIONS IV Administration Consider these facts: The average time required to place an IV line is 13 minutes1 IV placement attempts fail 26% of the time in adults and ...

ByEnable Injections


Rani Therapeutics Debuts on the Nasdaq: What uou should know About the Biopharma

Rani Therapeutics Debuts on the Nasdaq: What uou should know About the Biopharma

"Our mission is to, at the minimum give an alternative to, and hopefully end injections for patients who have to do that on a chronic basis, Imran said. For IV infusions, a patient has to go to hospitals every time, and in the case of self-injected options, they will have to find vessels every time, he said. ...

ByRani Therapeutics


Biorep Innovation Partner to COVID-19 Stem Cell Therapy Trial

Biorep Innovation Partner to COVID-19 Stem Cell Therapy Trial

After a lightning round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of COVID-19. The therapy uses ...

ByBiorep Technologies, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT